Publicaciones en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (12)

2021

  1. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

    Neurology, Vol. 97, Núm. 14, pp. E1367-E1381

2020

  1. A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice

    Brain Sciences, Vol. 10, Núm. 3

  2. Erratum: A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. (Brain sci. (2020) 10, 176)

    Brain Sciences

2018

  1. Phenomenology and disease progression of chorea-acanthocytosis patients in Spain

    Parkinsonism and Related Disorders, Vol. 49, pp. 17-21

  2. «Apuntes en Neurologia»: una sintesis de la evidencia en trastornos neurologicos comunes paroxisticos y en trastornos neurodegenerativos

    Revista de neurologia, Vol. 67, Núm. s01, pp. S1-S21

2016

  1. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression

    BMC Neurology, Vol. 16, Núm. 1

  2. Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression [BMC Neurol. 16, (2015), 26] DOI: 10.1186/s12883-016-0548-9

    BMC Neurology

2013

  1. Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages

    Revista de Neurologia, Vol. 56, Núm. 1, pp. 25-34

2010

  1. Efficacy and safety of pallidal stimulation in primary dystonia: Results of the Spanish multicentric study

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 81, Núm. 1, pp. 65-69

2009

  1. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease

    Movement Disorders, Vol. 24, Núm. 8, pp. 1154-1161

2008

  1. Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study

    Movement Disorders, Vol. 23, Núm. 8, pp. 1130-1136

2005

  1. Bilateral deep brain stimulation in Parkinson's disease: A multicentre study with 4 years follow-up

    Brain, Vol. 128, Núm. 10, pp. 2240-2249